Pfizer Denied New Trial In $200M Neurontin MDL

Law360, New York (July 29, 2011, 5:46 PM EDT) -- Pfizer Inc. on Wednesday lost its bid for a new trial in a multidistrict litigation in Massachusetts in which the drug company was ordered to pay $237 million to the Kaiser Foundation Health Plan for violating racketeering law in its marketing of pain drug Neurontin.

U.S. District Judge Patti B. Saris refused to reopen the evidence for Pfizer and its co-defendant, Pfizer unit Warner-Lambert Co., and shot down three of the defendants' arguments, including a claim that new evidence had surfaced.

The case is part of...
To view the full article, register now.